Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
24 February 2012

IN THIS ISSUE
FDA Warning Letter
Pfizer's generic deal
McNeil recall
Counterfeit Avastin


FDA issues warning letters for three Merck KGaA plants
The FDA has sent a Warning Letter to the chairman of the executive board of Merck KGaA regarding cGMP violations identified at three of its European facilities. More...
 
Pfizer eyes Chinese generics deal
Pfizer has signed an agreement with Chinese biopharmaceutical company Zhejiang Hisun Pharmaceuticals with the aim of establishing a $545-million joint venture to develop and commercialise branded generic medicines in both China and the global market. More...
 
McNeil recalls infants' medicine
McNeil Consumer Healthcare has voluntarily recalled approximately 574,000 bottles of its over-the-counter pain reliever and fever-reducer Infants' Tylenol Oral Suspension, 1 oz. Grape, after consumers complained of difficulties with the SimpleMeasure dosing system. More...
 
FDA and Roche warn of counterfeit Avastin
FDA and Genentech, a member of the Roche Group, have issued warnings about counterfeit versions of the injectable cancer drug, Avastin, circulating in the US. More...
 
Follow us on Twitter
We tweet regularly about the latest news, trends and rumours hitting the web about the bio/pharma industry. Follow us to make sure you don't miss out! More...
Key Topics:

Latest blog posts
Nanomaterials and TB treatments
FDA and Roche warn of counterfeit Avastin
Roche and Illumina ready the trenches
More blog posts

PTE Digital
Injectables: the pointed debate
Decoding the hype and fear of nanomedicines
Pharma's head in the clouds with cloud computing
More articles

Upcoming events
CPhI Japan (21–23 March | Japan)
World Companion Diagnostics Summit Europe (26–29 March | Germany)
ICH Q3D Metal Impurities Workshop (4–5 April | US)
More events

Products/Service Profiles
Hospira One 2 One

Hospira One 2 One® contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules. Broad range of capabilities: Biologics; Potent drugs; Vaccines; Cytotoxics; Beta-lactams; Lyophilization.
Read more


Event Profile
PDA

Parenteral Packaging, March 13-15, Berlin | Germany
PDA organizes this conference to address the technical and regulatory issues related to parenteral packaging. Chemical, physical and microbiological aspects will be considered and current regulatory challenges will be discussed. Two Training Courses on Container Closure Development or Selection and Utilization of Glass Containers in Pharmaceutical Packaging will be given Read more

 
Survey
Which is your preferred social media tool for professional use?
Twitter 10%
 
Facebook 12%
     
LinkedIn 64%
     
Google+ 10%
     
Other 4%

This week we would like to know...

During the past decade, what has been the most significant advance in sterile manufacturing?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.